We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Insmed Sells FOB Candidates, Facilities to Merck for $130 Million
Insmed Sells FOB Candidates, Facilities to Merck for $130 Million
February 17, 2009
Merck has signed an agreement to buy Virginia-based Insmed’s portfolio of follow-on biologic (FOB) candidates for $130 million in cash.